Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Liabilities (2019 - 2025)

Pulmonx (LUNG) has disclosed Total Liabilities for 7 consecutive years, with -$69.1 million as the latest value for Q2 2025.

  • Quarterly Total Liabilities fell 196.71% to -$69.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$69.1 million through Jun 2025, down 196.71% year-over-year, with the annual reading at $77.0 million for FY2024, 29.55% up from the prior year.
  • Total Liabilities for Q2 2025 was -$69.1 million at Pulmonx, down from $73.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $77.0 million in Q4 2024, with the low at -$202.8 million in Q3 2021.
  • Average Total Liabilities over 5 years is $4.1 million, with a median of $40.3 million recorded in 2021.
  • The sharpest move saw Total Liabilities plummeted 453.61% in 2023, then skyrocketed 153.33% in 2024.
  • Over 5 years, Total Liabilities stood at $41.9 million in 2021, then decreased by 5.4% to $39.7 million in 2022, then soared by 49.91% to $59.5 million in 2023, then increased by 29.55% to $77.0 million in 2024, then crashed by 189.68% to -$69.1 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at -$69.1 million, $73.1 million, and $77.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.